The researchers say that these findings support the long-held belief that insulin detemir levels are less predictable in hypoalbuminaemia; and as there was no difference in occurrence of hypoglycaemia in individuals with albumin over 3 g/dL, this confirms the equivalent safety of both insulins in the majority of people.